Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115760) titled 'A Randomized Controlled Trial on the Efficacy of Tympanic Membrane Injection of PTMSC Exosomes in the Treatment of Sudden Deafness' on Dec. 31, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Zhujiang Hospital of Southern Medical University

Condition: Sensorineural hearing loss

Intervention: Experimental group:Combined use of PTMSC exosome tympanic cavity injection with dexamethasone injection solution

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Experimental group:44;Control group:44;

Countries of Recruitment...